Orthobiologics Market Projected to Gain Significant Value through 2023 to 2033
The orthobiologics market is anticipated to thrive at an average CAGR of 3.0% between 2023 and 2033 . The market is estimated to reach US$ 8.1 billion by 2033 while it is valued at US$ 6 billion in 2023. - The precision-based orthobiologics products that provide ease to the patient with pain relief and bone strength are in high demand. - The use of orthobiologics as a regenerative medicine along with effective treatment is making it the first alternative for the patient with bone injury. - Rapid growth of the geriatric population, increasing rate of age-related fractures, and increasing implementations of advanced procedures are expected to drive the market growth. - Severe accidents lead to fatal injuries and bone displacements. Orthobiologics products and regenerative medicines work on these issues and deliver relief to the patient. - The government investment in regenerative medicines and orthobiologic products is hel